Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Drug Regulation01:25

Drug Regulation

3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

594
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
594
Synthetic Biology02:55

Synthetic Biology

5.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.7K
Biodiversity and Human Values01:24

Biodiversity and Human Values

17.3K
Human civilization relies on biodiversity in many ways. Sudden changes in species biodiversity result in environmental changes that can modify weather patterns and therefore human civilizations.
17.3K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

25
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Priorities for progress towards Sustainable Development Goal 15 'Life on land'.

Nature ecology & evolution·2023
Same author

The ultra-processed food industry in Africa.

Nature food·2023
Same author

Farmers' Rights and Digital Sequence Information: Crisis or Opportunity to Reclaim Stewardship Over Agrobiodiversity?

Frontiers in plant science·2021
Same author

Rethink the expansion of access and benefit sharing.

Science (New York, N.Y.)·2020
Same author

Rooibos settlement omits other marginalized people.

Nature·2020
Same author

The missing skill set in community management of tropical forests.

Conservation biology : the journal of the Society for Conservation Biology·2013

Related Experiment Video

Updated: Feb 22, 2026

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
09:49

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

Published on: October 31, 2019

23.3K

Fast Science and Sluggish Policy: The Herculean Task of Regulating Biodiscovery.

Rachel Wynberg1, Sarah A Laird2

  • 1Department of Environmental and Geographical Science, University of Cape Town, Private Bag, Rondebosch 770, South Africa; www.bio-economy.org.za.

Trends in Biotechnology
|October 2, 2017
PubMed
Summary

The Nagoya Protocol on Access and Benefit Sharing (ABS) needs updates to address new biodiscovery technologies. Innovative, transdisciplinary strategies are essential for regulating genetic resources and traditional knowledge access.

Keywords:
Nagoya protocolaccess and benefit sharingbioprospectingbiotechnologysynthetic biology

More Related Videos

Early Detection of Cyanobacterial Blooms and Associated Cyanotoxins using Fast Detection Strategy
07:13

Early Detection of Cyanobacterial Blooms and Associated Cyanotoxins using Fast Detection Strategy

Published on: February 25, 2021

4.5K
Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.7K

Related Experiment Videos

Last Updated: Feb 22, 2026

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
09:49

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

Published on: October 31, 2019

23.3K
Early Detection of Cyanobacterial Blooms and Associated Cyanotoxins using Fast Detection Strategy
07:13

Early Detection of Cyanobacterial Blooms and Associated Cyanotoxins using Fast Detection Strategy

Published on: February 25, 2021

4.5K
Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.7K

Area of Science:

  • Biodiscovery
  • Biotechnology Law
  • Environmental Science

Background:

  • The Nagoya Protocol established rules for access and benefit sharing (ABS) of genetic resources and traditional knowledge.
  • Current scientific and technological advancements in biodiscovery have outpaced the protocol's regulatory framework.

Purpose of the Study:

  • To highlight the inadequacy of existing ABS regulations in the face of emerging technologies.
  • To propose the necessity of innovative, transdisciplinary approaches for regulating ABS and new biotechnologies.

Main Methods:

  • Literature review of the Nagoya Protocol and its limitations.
  • Analysis of recent advancements in biodiscovery and associated technologies.
  • Conceptual framework development for transdisciplinary regulatory approaches.

Main Results:

  • Existing ABS frameworks are insufficient for current biodiscovery.
  • Emerging technologies require novel regulatory strategies.
  • Transdisciplinary collaboration is crucial for effective ABS governance.

Conclusions:

  • The Nagoya Protocol requires significant adaptation to remain relevant.
  • Innovative, transdisciplinary approaches are vital for governing access to genetic resources and traditional knowledge in the era of advanced biodiscovery.
  • Future regulations must integrate scientific, ethical, and legal perspectives.